MedPath
NMPA Product

复方氨林巴比妥注射液

Product approved by National Medical Products Administration (CN)

Basic Information

复方氨林巴比妥注射液

复方氨林巴比妥注射液

2ml:氨基比林0.1g,安替比林40mg,巴比妥18mg

注射剂(小容量注射剂)

Regulatory Information

国药准字H11022437

Approved

化学药品

August 11, 2021

Company Information

Active Ingredients

Compound Aminophenazone and Barbital Injection

© Copyright 2025. All Rights Reserved by MedPath